News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GenCorp Inc. (GY) Announces Issuance Of Additional $25 Million Of 4% Contingent Convertible Subordinated Notes Due 2024


10/19/2005 5:09:52 PM

SACRAMENTO, Calif., Jan. 29 /PRNewswire-FirstCall/ -- GenCorp Inc. announced today that it issued an additional $25 Million of its 4% Contingent Convertible Subordinated Notes due 2024 pursuant to the exercise, in full, of the option granted to one of the initial purchasers in connection with the private placement of notes announced on January 13, 2004. The Company intends to use the total net proceeds from the notes to repay outstanding indebtedness under its revolving credit facility, to prepay the payments that would otherwise be required in 2004 under its Term Loan A and for general corporate purposes.

(Photo: http://www.newscom.com/cgi-bin/prnh/20010108/SFM125LOGO )

The notes will be convertible into shares of the Company's common stock upon the happening of certain events.

These securities have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.

This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor will there be any sale of these securities in any jurisdiction where such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. The statements in this press release regarding the timing of the proposed offering and any other future aspects relating to the proposed offering and other statements which are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties, including, but not limited to, market conditions and the price and market for the securities proposed to be offered.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20010108/SFM125LOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, 1-888-776-6555 or +1-212-782-2840 GenCorp Inc.

CONTACT: investors, Yasmin Seyal, senior vice president & chieffinancial officer, +1-916-351-8585, or media, Linda Beech Cutler, vicepresident, Corporate Communications, +1-916-351-8650, both of GenCorp Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES